Scintigraphic Skeletal Changes in Uremic Patients on Regular Hemodialysis
Overview
Authors
Affiliations
99Tcm-polyphosphate (Tc-PP) bone scintigraphy was performed in 30 consecutive uremic patients on regular hemodialysis and compared with a normal control group. 27 of the patients (90%) had pathological accumulation on the scintigrams, while roentgenographic abnormalities were present in only 10 patients (33%), indicating that scintigraphy is superior to X-ray in the early detection of skeletal changes in uremic patients. In the group with the most pronounced uptake on the scintigrams there was a preponderance of previously kidney-transplanted patients, while no correlation could be demonstrated between the severity of the scintigraphic findings and the duration of the hemodialysis period, the anephric state of the patients, the underlying kidney disease or the sex. It is suggested that intensive glucocorticoid treatment, even of short duration in the previously kidney-transplanted patients, may aggravate uremic osteodystrophy.
Bone scintigraphy and densitometry in symptomatic haemodialysis bone disease.
Alberts C, VAN DER SCHOOT J Eur J Nucl Med. 1981; 6(11):505-9.
PMID: 7327186 DOI: 10.1007/BF00255882.
de Graaf P, te Velde J, Pauwels E, Schicht I, Kleiverda K, de GRAEFF J Eur J Nucl Med. 1982; 7(4):152-4.
PMID: 7075618 DOI: 10.1007/BF00443921.
Treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol.
Velentzas C, Oreopoulos D, Pierratos A, MEEMA H, RABINOVICH S, MEINDOK H Can Med Assoc J. 1981; 124(5):577-83.
PMID: 6894103 PMC: 1705195.
Deconvolution analysis of 99mTc-methylene diphosphonate kinetics in metabolic bone disease.
Knop J, Kroger E, Stritzke P, Schneider C, Kruse H Eur J Nucl Med. 1981; 6(2):63-7.
PMID: 6451429 DOI: 10.1007/BF00253715.
Observations on computerized quantitative bone scintigraphy in renal osteodystrophy.
de Graaf P, Pauwels E, Vos P, Schicht I, te Velde J, de GRAEFF J Eur J Nucl Med. 1984; 9(9):419-25.
PMID: 6437823 DOI: 10.1007/BF00295578.